MCRA Announces Hassan F. Abdallah as New Head of Healthcare Compliance

2023-11-07
高管变更
WASHINGTON, Nov. 7, 2023 /PRNewswire/ -- MCRA, LLC, a leading medical device focused regulatory advisory firm and clinical research organization (CRO) integrating U.S. and International Regulatory Affairs, Clinical Trial Operations, Reimbursement and Market Access, Healthcare Compliance, Cybersecurity, Quality Assurance, and Japan Distribution Logistics (DMAH) is pleased to announce the hiring of Hassan F. Abdallah, JD, CHC, CPCM as the Head of Healthcare Compliance. As compliance requirements shift with the advent of new technology, MCRA has hired Mr. Abdallah to help clients navigate this complex landscape.
Continue Reading
Hassan Abdallah is an accomplished and seasoned professional in the field of healthcare compliance. Prior to joining MCRA, Mr. Abdallah served in several compliance leadership positions, overseeing compliance program development, audit representation, and corporate compliance program implementation. His expertise has been pivotal in mitigating significant fraud, waste, and abuse recovery attempts and providing regulatory guidance on multimillion-dollar healthcare transactions. He brings an expansive knowledge base and organizational acumen in regulatory compliance, leveraging his Juris Doctorate (J.D.), Certified Healthcare Compliance Officer (CHC) and Certified Professional Contract Manager (CPCM) designations.
MCRA is pleased to announce the hiring of Hassan F. Abdallah as the Head of Healthcare Compliance.
Post this
At MCRA, Mr. Abdallah serves as a valuable member of project teams, functioning as the chief subject matter expert in healthcare compliance and ethics, to ensure adherence to regulations, solve complex compliance challenges, manage risks, promote ethical conduct, and safeguard reputations. Mr. Abdallah will offer consultation services to MCRA's clients, assisting them with the design, creation, and execution of healthcare compliance programs, as well as evaluate and enhance existing programs. Mr. Abdallah will serve as the outsourced Chief Compliance Officer (CCO), or Privacy Officer as needed for MCRA's clients. Additionally, he will be involved in risk assessments, internal audits, compliance issue resolution, corporate compliance training, HIPAA Privacy Program development, and other key compliance initiatives.
David Lown, President of MCRA, said "MCRA began offering healthcare compliance advisory services to our clients in 2005, as we recognized an effective compliance program is a fundamental business requirement for any healthcare organization. Given Hassan's strong compliance background and expertise, we are very happy to have him join our team, particularly in today's complex legal and regulatory environment".
Mr. Abdallah said, "I am excited to join the MCRA team and utilize my tested regulatory experience and skillset to service MCRA clients on the best avenues to building a compliance framework for their business. This will allow them to adapt to shifting compliance needs, while providing cutting edge patient care."
About MCRA, LLC: MCRA is the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm. MCRA delivers to its client's industry experience, integrating its six business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA's integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. www.mcra.com
About Viscogliosi Brothers, LLC: Viscogliosi Brothers, LLC (VB), founded MCRA in 2004. VB is headquartered in New York City and specialized in funding venture capital, private equity, and merchant banking activities for the neuromusculoskeletal industry. VB is dedicated to financing healthcare innovation. www.vbllc.com
For more information, please contact:
Alyssa Howard, Vice President, Business Development
Phone: 215.870.3952 | Email: [email protected]
SOURCE MCRA, LLC
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。